Cargando…
Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma
The long non-coding RNA (lncRNA) NKILA, localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of NKILA, it is hypothesized as a tumor suppressor lncRNA silenced by promoter DNA methylation in non-Hodgkin’s l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774545/ https://www.ncbi.nlm.nih.gov/pubmed/35052468 http://dx.doi.org/10.3390/genes13010128 |
_version_ | 1784636373332918272 |
---|---|
author | Zhang, Min-Yue Calin, George Deng, Ming-Dan Au-Yeung, Rex K. H. Wang, Lu-Qian Chim, Chor-Sang |
author_facet | Zhang, Min-Yue Calin, George Deng, Ming-Dan Au-Yeung, Rex K. H. Wang, Lu-Qian Chim, Chor-Sang |
author_sort | Zhang, Min-Yue |
collection | PubMed |
description | The long non-coding RNA (lncRNA) NKILA, localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of NKILA, it is hypothesized as a tumor suppressor lncRNA silenced by promoter DNA methylation in non-Hodgkin’s lymphoma (NHL). By pyrosequencing-verified methylation-specific PCR, NKILA methylation was detected in 1/10 (10%) NHL cell lines, but not in normal peripheral blood buffy coats or tonsils. NKILA methylation correlated with the repression of NKILA in cell lines. Hypomethylation treatment with 5-Aza-2′-deoxycytidine resulted in promoter demethylation and the re-expression of NKILA. In 102 NHL primary samples, NKILA was methylated in 29 (51.79%) diffuse large B-cell lymphoma (DLBCL) and 4 (20%) peripheral T-cell lymphoma cases, but unmethylated in all 26 mantle cell lymphoma cases. Mechanistically, the knockdown of NKILA resulted in promoting IkBα phosphorylation, associated with nucleus translocation of total p65 and phosphorylated p65 in SU-DHL-1 cells, hence constitutive NF-κB activation. Functionally, the knockdown of NKILA in SU-DHL-1 cells led to decreased cell death and increased cellular proliferation. Collectively, NKILA was a tumor suppressor lncRNA frequently hypermethylated in DLBCL. Promoter DNA methylation-mediated NKILA silencing resulted in increased cellular proliferation and decreased cell death via the repression of NF-κB signaling in NHL. |
format | Online Article Text |
id | pubmed-8774545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87745452022-01-21 Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma Zhang, Min-Yue Calin, George Deng, Ming-Dan Au-Yeung, Rex K. H. Wang, Lu-Qian Chim, Chor-Sang Genes (Basel) Article The long non-coding RNA (lncRNA) NKILA, localized to 20q13.31, is a negative regulator of NF-κB signaling implicated in carcinogenesis. As a CpG island is embedded in the promoter region of NKILA, it is hypothesized as a tumor suppressor lncRNA silenced by promoter DNA methylation in non-Hodgkin’s lymphoma (NHL). By pyrosequencing-verified methylation-specific PCR, NKILA methylation was detected in 1/10 (10%) NHL cell lines, but not in normal peripheral blood buffy coats or tonsils. NKILA methylation correlated with the repression of NKILA in cell lines. Hypomethylation treatment with 5-Aza-2′-deoxycytidine resulted in promoter demethylation and the re-expression of NKILA. In 102 NHL primary samples, NKILA was methylated in 29 (51.79%) diffuse large B-cell lymphoma (DLBCL) and 4 (20%) peripheral T-cell lymphoma cases, but unmethylated in all 26 mantle cell lymphoma cases. Mechanistically, the knockdown of NKILA resulted in promoting IkBα phosphorylation, associated with nucleus translocation of total p65 and phosphorylated p65 in SU-DHL-1 cells, hence constitutive NF-κB activation. Functionally, the knockdown of NKILA in SU-DHL-1 cells led to decreased cell death and increased cellular proliferation. Collectively, NKILA was a tumor suppressor lncRNA frequently hypermethylated in DLBCL. Promoter DNA methylation-mediated NKILA silencing resulted in increased cellular proliferation and decreased cell death via the repression of NF-κB signaling in NHL. MDPI 2022-01-11 /pmc/articles/PMC8774545/ /pubmed/35052468 http://dx.doi.org/10.3390/genes13010128 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Min-Yue Calin, George Deng, Ming-Dan Au-Yeung, Rex K. H. Wang, Lu-Qian Chim, Chor-Sang Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title | Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title_full | Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title_fullStr | Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title_full_unstemmed | Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title_short | Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma |
title_sort | epigenetic silencing of tumor suppressor lncrna nkila: implication on nf-κb signaling in non-hodgkin’s lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774545/ https://www.ncbi.nlm.nih.gov/pubmed/35052468 http://dx.doi.org/10.3390/genes13010128 |
work_keys_str_mv | AT zhangminyue epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma AT calingeorge epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma AT dengmingdan epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma AT auyeungrexkh epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma AT wangluqian epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma AT chimchorsang epigeneticsilencingoftumorsuppressorlncrnankilaimplicationonnfkbsignalinginnonhodgkinslymphoma |